Skip to content
HomeLatest newsJohnson & Johnson named to Glassdoor’s 2018 list of Best Places to Work
A photo of a woman opening two glass doors

Johnson & Johnson named to Glassdoor’s 2018 list of Best Places to Work

The company nabbed a top spot on the annual list—based entirely on positive reviews from its own employees.

With 2017 drawing to a close, Glassdoor has released its 2018 Employees’ Choice Awards for the Best Places to Work, with Johnson & Johnson placing #38 on the list.
Glassdoor tallies the rankings for its annual list based entirely on employee reviews, factoring in such things as company culture and values, career opportunities and work/life balance.

In anonymous Glassdoor reviews submitted throughout the year, Johnson & Johnson employees praised the company’s wide range of benefits, work/life balance ethos and Credo-based culture—86% of Glassdoor reviewers said they’d recommend the company to a friend.

When it comes to caring for employees, Johnson & Johnson continues to be an industry leader by offering such benefits as global parental leave, military leave and adoption and surrogacy assistance.

Johnson & Johnson employees also showed appreciation for Chairman and CEO Alex Gorsky: 95% of reviewers approved of Gorsky’s leadership, which helped him secure a spot on Glassdoor’s 2017 Highest Rated CEOs list.

When it comes to caring for employees, Johnson & Johnson continues to be an industry leader by offering such benefits as global parental leave, military leave and adoption and surrogacy assistance.

Johnson & Johnson has also taken steps toward its goal of having the world’s healthiest workforce: 90% of its employees worldwide have access to programs and services that support healthy living.

Johnson & Johnson has a 130-year legacy of supporting its employees—of always putting people first.

One Glassdoor reviewer put it best: “What makes J&J is the people who work here.”

More from Johnson & Johnson

This scientist couldn’t save his father from lung cancer—but the targeted treatments Robert Zhao, Ph.D., has since developed have helped countless others

Learn more about Zhao, his partnership with Johnson & Johnson and antibody-drug conjugates—a new type of cancer therapy that targets and kills cancer cells without harming healthy cells.

After their husbands were diagnosed with multiple myeloma, these 3 care partners became health equity activists

Kimberly Alexander, Michelle Ware-Ivy and Marsha Calloway-Campbell learned firsthand that Black individuals develop multiple myeloma at higher rates. That’s why they joined Johnson & Johnson’s That’s My Word® health equity campaign, which builds awareness about the disparities surrounding this rare blood cancer.

How Johnson & Johnson is working to get medications to people around the world who need them most

In the just-released 2024 Access to Medicine Index, the company ranks among the top 5 improving access to medicines.